Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 25, 2024 | June 27, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 25, 2024 · Filed June 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 14,756 |
Reported balance
After 2024-06-25 transaction · row 1
1 source rowRow 1 · 2024-06-25 · Grant · Acquired 748 · Balance 14,756 F1: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 2,100 |
Reported balance
Holding disclosure · report date 2024-06-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,100 |
Filing footnotes · ownership attribution and instrument terms
F1: Granted pursuant to the CME Group Director Stock Plan, as amended and restated.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2024 Filed Jun 27, 2024 00:48 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 748 | $194.10 | $145,186.80 |
DisclosureSEC source: 0001156375-24-000134 · wk-form4_1719449306.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,756 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 21:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 650 | $201.44 | $130,937.04 |
DisclosureSEC source: 0001156375-24-000084 · wk-form4_1717796802.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,008 Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:30 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 750 | $206.09 | $154,565.25 |
DisclosureSEC source: 0001156375-23-000133 · wf-form4_169161302413053.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,658 F1 · price: On August 9, 2023, Mr. Glickman sold an aggregate of 750 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $206.00 to $206.2950. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:16 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 811 | $178.89 | $145,079.79 |
DisclosureSEC source: 0001156375-23-000100 · wf-form4_168796895854442.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,408 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| August 31, 2022 Filed Aug 31, 2022 19:32 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 500 | $196.39 | $98,193.95 |
DisclosureSEC source: 0001156375-22-000219 · wf-form4_166197434660574.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 14:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 844 | $209.44 | $176,767.36 |
DisclosureSEC source: 0001156375-22-000203 · wf-form4_165651322667114.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,097 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 15:35 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 750 | $234.30 | $175,725.00 |
DisclosureSEC source: 0001156375-22-000080 · wf-form4_164623531791772.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,253 Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:22 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000029 · wf-form4_164322851209407.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,003 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 00:56 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 551 | $218.12 | $120,184.12 |
DisclosureSEC source: 0001156375-21-000077 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,956 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 14:41 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 900 | $173.22 | $155,898.00 |
DisclosureSEC source: 0001156375-20-000085 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,405 Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000058 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,305 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| August 28, 2019 Filed Aug 28, 2019 20:35 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 500 | $216.01 | $108,005.00 |
DisclosureSEC source: 0001156375-19-000091 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,593 Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:30 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 606 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000064 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,093 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:09 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000110 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,487 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:40 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000064 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,400 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 21:33 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 850 | $126.65 | $107,652.50 |
DisclosureSEC source: 0001156375-17-000087 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,799 Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:00 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000068 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,649 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.